Nat Clin Pract Neurol. 2007;3(9):505-516. Myoclonic Status Epilepticus. Myoclonic SE is characterized by continuous, usually generalized, myoclonias of cortical origin. The inclusion of myoclonic ...
UC's Brandon Foreman, MD, explained the trial focused on status epilepticus (SE), a disorder he described as "seizures that don't stop." Seizures are the second most common neurologic emergency in ...
One of the trial’s co-primary endpoints—cessation of status epilepticus (SE) within 30 minutes—was successfully met, with 80% ...
We’re exploring some of the most common triggers of seizure clusters and practical tips on how to avoid or manage these risks ...
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and ...
The co-primary endpoints were the proportion of patients with status epilepticus (SE) cessation within 30 minutes and the proportion of patients not progressing to IV anesthesia within 36 hours of ...
A fundraising campaign has been set up for a brave 11-year-old Waterford city boy who suffers from severe epilepsy and other ...
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) is set to present significant findings from its Phase 3 RAISE trial ...
clearance for diagnosing electrographic status epilepticus. Subsequently, the Clarity algorithm received a New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services (CMS ...
today announced that additional data from the Phase 3 RAISE trial in refractory status epilepticus and retrospective claims-based data from patients with status epilepticus will be presented at ...
The family of a Waterford boy who is the only person in Ireland with a rare disease have revealed how he can’t attend school ...
Nonconvulsive status epilepticus (NCSE) encompasses a wide range of diagnoses with variable outcomes and treatment recommendations. In children, NCSE can be observed in various conditions ...